NUWE Soars 170%
Nuwellis stock jumps on study acceptance
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.
News Feed
3 results loaded, newest first. End of these results. The latest changes are still being indexed. Try again shortly for updated results.
GCTK - closed +70% in AHs session (uber Nano-cap) PR: Glucotrack's Subsidiary, Lōkahi Therapeutics, Advances LT-100 Development Strategy Tow
GCTK - closed +70% in AHs session (uber Nano-cap) PR: Glucotrack's Subsidiary, Lōkahi Therapeutics, Advances LT-100 Development Strategy Toward Single-Injection Administration; FDA Type C Meeting and Nonclinical Study Advance Strategy To Transition LT-100 From 15 Injections To One
GCTK Advances LT-100 Development
GCTK advances LT-100 development strategy